Delivery Systems for Intradermal Vaccination

  • Y. C. Kim
  • C. Jarrahian
  • D. Zehrung
  • S. Mitragotri
  • M. R. Prausnitz
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 351)


Intradermal (ID) vaccination can offer improved immunity and simpler logistics of delivery, but its use in medicine is limited by the need for simple, reliable methods of ID delivery. ID injection by the Mantoux technique requires special training and may not reliably target skin, but is nonetheless used currently for BCG and rabies vaccination. Scarification using a bifurcated needle was extensively used for smallpox eradication, but provides variable and inefficient delivery into the skin. Recently, ID vaccination has been simplified by introduction of a simple-to-use hollow microneedle that has been approved for ID injection of influenza vaccine in Europe. Various designs of hollow microneedles have been studied preclinically and in humans. Vaccines can also be injected into skin using needle-free devices, such as jet injection, which is receiving renewed clinical attention for ID vaccination. Projectile delivery using powder and gold particles (i.e., gene gun) have also been used clinically for ID vaccination. Building off the scarification approach, a number of preclinical studies have examined solid microneedle patches for use with vaccine coated onto metal microneedles, encapsulated within dissolving microneedles or added topically to skin after microneedle pretreatment, as well as adapting tattoo guns for ID vaccination. Finally, technologies designed to increase skin permeability in combination with a vaccine patch have been studied through the use of skin abrasion, ultrasound, electroporation, chemical enhancers, and thermal ablation. The prospects for bringing ID vaccination into more widespread clinical practice are encouraging, given the large number of technologies for ID delivery under development.


  1. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14:375–381PubMedGoogle Scholar
  2. Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR, Babiuk LA, Townsend H, Mutwiri G (2009) Poly [di (carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci USA 106:18936–18941PubMedGoogle Scholar
  3. Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P (2009) Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 27:7304–7312PubMedGoogle Scholar
  4. Ayoola EA (1984) Hepatitis B vaccine in developing countries: problems and prospects. IARC Sci Publ 63:297–305PubMedGoogle Scholar
  5. Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D, Widera G, Babiuk LA (2002) Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20:3399–3408PubMedGoogle Scholar
  6. Baxby D (2002) Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine 20:2140–2149PubMedGoogle Scholar
  7. Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G (2004) Serum antibody responses after intradermal vaccination against influenza. New Engl J Med 351:2286–2294PubMedGoogle Scholar
  8. Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE (2007) Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 25:6755–6763PubMedGoogle Scholar
  9. Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, Demanet E, Heijmans S, Van Belle P, Weber F, Salamand C (2009) Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 7:13PubMedGoogle Scholar
  10. Bernard KW, Roberts MA, Sumner J, Winkler WG, Mallonee J, Baer GM, Chaney R (1982) Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 247:1138–1142PubMedGoogle Scholar
  11. Bernard KW, Mallonee J, Wright JC, Reid FL, Makintubee S, Parker RA, Dwyer DM, Winkler WG (1987) Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. JAMA 257:1059–1063PubMedGoogle Scholar
  12. Bilitewski U, Genrich M, Kadow S, Mersal G (2003) Biochemical analysis with microfluidic systems. Anal Bioanal Chem 377:556–569PubMedGoogle Scholar
  13. Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TNM, Haanen JBAG (2005) A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11:899–904PubMedGoogle Scholar
  14. Bramson J, Dayball K, Evelegh C, Wan YH, Page D, Smith A (2003) Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 10:251–260PubMedGoogle Scholar
  15. Bremseth DL, Pass F (2001) Delivery of insulin by jet injection: recent observations. Diabetes Technol Ther 3:225–232PubMedGoogle Scholar
  16. Brindle RJ, Morris CA, Berger R, Kurtz JB (1994) Inadequate response to intradermal hepatitis A vaccine. Vaccine 12:483–484PubMedGoogle Scholar
  17. Burland WL (1969) Measles vaccination by the intradermal route. Postgrad Med J 45:323–326PubMedGoogle Scholar
  18. Carlsson U, Brudin L, Eliasson I, Hansson BG (1996) Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative. Scand J Infect Dis 28:435–438PubMedGoogle Scholar
  19. Chen W, Gluud C (2005) Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev, Issue 4. Art. No.: CD000100. doi:10.1002/14651858.CD000100.pub3
  20. Chen D, Zuleger C, Chu Q, Maa YF, Osorio J, Payne LG (2002) Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. AIDS Res Hum Retroviruses 18:715–722PubMedGoogle Scholar
  21. Chen D, Burger M, Chu Q, Endres R, Zuleger C, Dean H, Payne LG (2004) Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 103:147–153PubMedGoogle Scholar
  22. Chen XF, Prow TW, Crichton ML, Jenkins DWK, Roberts MS, Frazer IH, Fernando GJP, Kendall MAF (2009) Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release 139:212–220PubMedGoogle Scholar
  23. Coberly JS, Townsend T, Repke J, Fields H, Margolis H, Halsey NA (1994) Suboptimal response following intradermal hepatitis B vaccine in infants. Vaccine 12:984–987PubMedGoogle Scholar
  24. Cosman F, Lane NE, Bolognese MA, Zanchetta JR, Garcia-Hernandez PA, Sees K, Matriano JA, Gaumer K, Daddona PE (2009) Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 95:151–158PubMedGoogle Scholar
  25. Dahlan A, Alpar HO, Stickings P, Sesardic D, Murdan S (2009) Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm 368:123–128PubMedGoogle Scholar
  26. Darmanger AM, Nekzad SM, Kuis M, Tendam HG (1977) BCG vaccination by bifurcated needle in a pilot vaccination program. Bull WHO 55:49–61PubMedGoogle Scholar
  27. Davis SP, Martanto W, Allen MG, Prausnitz MR (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 52:909–915PubMedGoogle Scholar
  28. de Moraes JC, Leon ME, Souza VA, Pannuti C, Travisanello C, Halsey NA, de Quadros CA (1994) Intradermal administration of measles vaccines. Bull Pan Am Health Organ 28:250–255PubMedGoogle Scholar
  29. Dean HJ, Chen D (2004) Epidermal powder immunization against influenza. Vaccine 23:681–686PubMedGoogle Scholar
  30. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, Monath TP, Mikszta JA (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccine 1:106–111Google Scholar
  31. Dimache G, Stoean C, Durbaca S, Croitoru M, Ionescu M, Nedelcu IN, Corbu I (1990) Study of specific immune response to unadsorbed concentrated tetanus vaccine administered by intradermal route to non-immunized persons in the last ten years. Arch Roum Pathol Exp Microbiol 49:51–62PubMedGoogle Scholar
  32. Ding Z, Van Riet E, Romeijn S, Kersten GFA, Jiskoot W, Bouwstra JA (2009a) Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res 26:1635–1643PubMedGoogle Scholar
  33. Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, Kersten G, Bouwstra JA (2009b) Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release 136:71–78PubMedGoogle Scholar
  34. Donnelly RF, Singh TRR, Tunney MM, Morrow DIJ, McCarron PA, O’Mahony C, Woolfson AD (2009) Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 26:2513–2522PubMedGoogle Scholar
  35. Drabick JJ, Glasspool-Malone J, King A, Malone RW (2001) Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 3:249–255PubMedGoogle Scholar
  36. Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ (2006) Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 24:4475–4481PubMedGoogle Scholar
  37. Epstein JE, Gorak EJ, Charoenvit Y, Wang R, Freydberg N, Osinowo O, Richie TL, Stoltz EL, Trespalacios F, Nerges J, Ng J, Fallarme-Majam V, Abot E, Goh L, Parker S, Kumar S, Hedstrom RC, Norman J, Stout R, Hoffman SL (2002) Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gene Ther 13:1551–1560PubMedGoogle Scholar
  38. Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78:85–91PubMedGoogle Scholar
  39. Etchart N, Hennino A, Friede M, Dahel K, Dupouy M, Goujon-Henry C, Nicolas JF, Kaiserlian D (2007) Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Vaccine 25:6891–6899PubMedGoogle Scholar
  40. Fernando GJP, Chen XF, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, Frazer IH, Brown LE, Kendall MAF (2010) Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One 5:e10266PubMedGoogle Scholar
  41. Fishbein DB, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC (1987) Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study. J Infect Dis 156:50–55PubMedGoogle Scholar
  42. Flynn PM, Shenep JL, Mao L, Crawford R, Williams BF, Williams BG (1994) Influence of needle gauge in Mantoux skin testing. Chest 106:1463–1465PubMedGoogle Scholar
  43. Foldvari M, Babiuk S, Badea I (2006) DNA delivery for vaccination and therapeutics through the skin. Curr Drug Deliv 3:17–28PubMedGoogle Scholar
  44. Frech SA, Kenney RT, Spyr CA, Lazar H, Viret JF, Herzog C, Gluck R, Glenn GM (2005) Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23:946–950PubMedGoogle Scholar
  45. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Melendez-Romero JH, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA, Glenn GM (2008) Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 371:2019–2025PubMedGoogle Scholar
  46. Frerichs DM, Ellingsworth LR, Frech SA, Flyer DC, Villar CP, Yu J, Glenn GM (2008) Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine 26:2782–2787PubMedGoogle Scholar
  47. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB (2002) Clinical responses to undiluted and diluted smallpox vaccine. New Engl J Med 346:1265–1274PubMedGoogle Scholar
  48. Gardeniers HJGE, Luttge R, Berenschot EJW, de Boer MJ, Yeshurun SY, Hefetz M, van’t Oever R, van den Berg A (2003) Silicon micromachined hollow microneedles for transdermal liquid transport. J MEMS 12:855–862Google Scholar
  49. Garg S, Hoelscher M, Belser JA, Wang C, Jayashankar L, Guo Z, Durland RH, Katz JM, Sambhara S (2007) Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol 14:926–928PubMedGoogle Scholar
  50. Gehl J (2008) Electroporation for drug and gene delivery in the clinic: doctors go electric. Methods Mol Biol 423:351–359PubMedGoogle Scholar
  51. Gill HS, Prausnitz MR (2007a) Coated microneedles for transdermal delivery. J Control Release 117:227–237PubMedGoogle Scholar
  52. Gill HS, Prausnitz MR (2007b) Coating formulations for microneedles. Pharm Res 24:1369–1380PubMedGoogle Scholar
  53. Gill HS, Prausnitz MR (2008) Pocketed microneedles for drug delivery to the skin. J Phys Chem Solids 69:1537–1541PubMedGoogle Scholar
  54. Gill HS, Andrews SN, Sakthivel SK, Fedanov A, Williams IR, Garber DA, Priddy FH, Yellin S, Feinberg MB, Staprans SI, Prausnitz MR (2009) Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur J Pharm Sci 38:95–103PubMedGoogle Scholar
  55. Gill HS, Sõderholm J, Prausnitz MR, Sällberg M (2010) Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 17:811–814PubMedGoogle Scholar
  56. Glenn GM, Kenney RT (2006) Mass vaccination: solutions in the skin. Curr Top Microbiol Immunol 304:247–268PubMedGoogle Scholar
  57. Gomez V, Palomeque FS, Feris J et al. (2010) Still-blinded safety and immunogenicity data from a trial of reduced-dose, intradermal, influenza vaccination by needle-free jet injection. 13th Annual Conference on Vaccine Research, Bethesda, MDGoogle Scholar
  58. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:1159–1169PubMedGoogle Scholar
  59. Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L, Glenn GM (2003) Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol 77:5218–5225PubMedGoogle Scholar
  60. Han M, Kim DK, Kang SH, Yoon HR, Kim BY, Lee SS, Kim KD, Lee HG (2009) Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sens Act B 137:274–280Google Scholar
  61. Heijtink RA, Knol RM, Schalm SW (1989) Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. J Med Virol 27:151–154PubMedGoogle Scholar
  62. Henderson DA, Borio BL, Grabenstein JD (2008) Smallpox and vaccinia. In: Plotkin S, Orenstein WA, Offit PA (eds) Vaccines, vol 5. Elsevier, Amsterdam, pp 773–803Google Scholar
  63. Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198:1491–1501PubMedGoogle Scholar
  64. Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M (2008) Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198:650–658PubMedGoogle Scholar
  65. Howard A, Mercer P, Nataraj HC, Kang BC (1997) Bevel-down superior to bevel-up in intradermal skin testing. Ann Allergy Asthma Immunol 78:594–596PubMedGoogle Scholar
  66. Inoue J, Aramaki Y (2007) Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides. Vaccine 25:1007–1013PubMedGoogle Scholar
  67. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K (2006) Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 29:82–88PubMedGoogle Scholar
  68. Jones S, Evans K, McElwaine-Johnn H, Sharpe M, Oxford J, Lambkin-Williams R, Mant T, Nolan A, Zambon M, Ellis J, Beadle J, Loudon PT (2009) DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine 27:2506–2512PubMedGoogle Scholar
  69. Kalluri H, Banga AK (2011) Formation and closure of microchannels in skin following microporation. Pharm Res 28:82–94PubMedGoogle Scholar
  70. Karande P, Jain A, Mitragotri S (2004) Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192–197PubMedGoogle Scholar
  71. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S (2005) Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688–4693PubMedGoogle Scholar
  72. Karande P, Arora A, Pham TK, Stevens D, Wojicki A, Mitragotri S (2009) Transcutaneous immunization using common chemicals. J Control Release 138:134–140PubMedGoogle Scholar
  73. Kermode M (2004) Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 19:95–103PubMedGoogle Scholar
  74. Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR (2009) Improved influenza vaccination in the skin using vaccine coated-microneedles. Vaccine 27:6932–6938PubMedGoogle Scholar
  75. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010a) Fomulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech 11:1193–1201PubMedGoogle Scholar
  76. Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR (2010b) Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 201:190–198PubMedGoogle Scholar
  77. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010c) Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 142:187–195PubMedGoogle Scholar
  78. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2011) Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 28:135–144PubMedGoogle Scholar
  79. Kok PW, Kenya PR, Ensering H (1983) Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration. Trans Roy Soc Trop Med Hyg 77:171–176PubMedGoogle Scholar
  80. Kolli CS, Banga AK (2008) Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 25:104–113PubMedGoogle Scholar
  81. Koutsonanos DG, Martin MdP, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Skountzou I (2009) Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4:e4773PubMedGoogle Scholar
  82. Laddy DJ, Yan J, Khan AS, Andersen H, Cohn A, Greenhouse J, Lewis M, Manischewitz J, King LR, Golding H, Draghia-Akli R, Weiner DB (2009) Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 83:4624–4630PubMedGoogle Scholar
  83. Lambert PH, Laurent PE (2008) Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26:3197–3208PubMedGoogle Scholar
  84. Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG (2007) Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25:8833–8842PubMedGoogle Scholar
  85. Lee JW, Park JH, Prausnitz MR (2008) Dissolving microneedles for transdermal drug delivery. Biomaterials 29:2113–2124PubMedGoogle Scholar
  86. Lee K, Lee HC, Lee DS, Jung H (2010) Drawing lithography: three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle. Adv Mat 22:483–486Google Scholar
  87. Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G (2008) Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 26:6614–6619PubMedGoogle Scholar
  88. Luttge R, Berenschot EJW, de Boer MJ, Altpeter DM, Vrouwe EX, van den Berg A, Elwenspoek M (2007) Integrated lithographic molding for microneedle-based devices. J MEMS 16:872–884Google Scholar
  89. Mantoux C (1909) Tuberculin intradermo reactions in the treatment of tuberculosis: intradermi-tuberculisation. C R Hebd Seances Acad Sci 148:996–998Google Scholar
  90. Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE (2002) Macroflux® microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19:63–70PubMedGoogle Scholar
  91. Matyas GR, Friedlander AM, Glenn GM, Little S, Yu J, Alving CR (2004) Needle-free skin patch vaccination method for anthrax. Infect Immun 72:1181–1183PubMedGoogle Scholar
  92. Medi BM, Singh J (2008) Delivery of DNA into skin via electroporation. Methods Mol Biol 423:225–232PubMedGoogle Scholar
  93. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8:415–419PubMedGoogle Scholar
  94. Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP, Brittingham JM, Huang J, Hwang CR, Ferriter M, Jiang G, Mar K, Saikh KU, Stiles BG, Roy CJ, Ulrich RG, Harvey NG (2005) Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis 191:278–288PubMedGoogle Scholar
  95. Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 74:6806–6810PubMedGoogle Scholar
  96. Millar JD, Foege WH (1969) Status of eradication of smallpox (and control of measles) in West and Central Africa. J Infect Dis 120:725–732PubMedGoogle Scholar
  97. Miller MA, Pisani E (1999) The cost of unsafe injections. Bull WHO 77:808–811PubMedGoogle Scholar
  98. Milne A, Allwood GK, Pearce NE, Lucas CR, Krugman S (1986) Low dose hepatitis B vaccination in children. New Zeal Med J 99:47–49PubMedGoogle Scholar
  99. Mitragotri S (2005) Immunization without needles. Nat Rev Immun 5:905–916Google Scholar
  100. Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban MMA, Sharif SM, van der Avoort HGAM, Pallansch MA, Malankar P, Burton A, Sreevatsava M, Sutter RW (2010) Fractional doses of inactivated poliovirus vaccine in Oman. New Engl J Med 362:2351–2359PubMedGoogle Scholar
  101. Ng KW, Pearton M, Coulman S, Anstey A, Gateley C, Morrissey A, Allender C, Birchall J (2009) Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine 27:5948–5955PubMedGoogle Scholar
  102. Nicolas JF, Guy B (2008) Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7:1201–1214PubMedGoogle Scholar
  103. Nirmal S, Cherian T, Samuel BU, Rajasingh J, Raghupathy P, John TJ (1998) Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine 16:928–931PubMedGoogle Scholar
  104. Oh SJ, Harrison T, D’Andrea A, Kwon SY, Burkoth TL, Burke R (2006) Intradermal influenza vaccine delivery using skin-penetrating dissolvable vaccine microneedles. AAPS Annual Meeting. San Antonio, TXGoogle Scholar
  105. Oosterhuis K, van den Berg JH, Schumacher TN, Haanen JBAG (2010) DNA vaccines and intradermal vaccination by DNA tattooing. Curr Top Microbiol Immunol 351:221–250Google Scholar
  106. Osorio JE, Zuleger CL, Burger M, Chu Q, Payne LG, Chen D (2003) Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunol Cell Biol 81:52–58PubMedGoogle Scholar
  107. Pancharoen C, Mekmullica J, Thisyakorn U, Kasempimolporn S, Wilde H, Herzog C (2005) Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs. Clin Infect Dis 41:1537–1540PubMedGoogle Scholar
  108. Park JH, Allen MG, Prausnitz MR (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 104:51–66PubMedGoogle Scholar
  109. Park JH, Allen MG, Prausnitz MR (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res 23:1008–1019PubMedGoogle Scholar
  110. Parker V (1984) Jet gun or syringe? A trial of alternative methods of BCG vaccination. Public Health 98:315–320PubMedGoogle Scholar
  111. PATH (2009) Intradermal delivery of vaccines: a review of the literature and the potential for development for use in low- and middle-income countries. PATH/WHO, Ferney Voltaire, France. 14 Sept 2010.
  112. Paul SS, Raveendra NK, Chhabra AK, Verma M (1978) Comparison of BCG inoculation by conventional intradermal and jet methods. Indian Pediatr 15:341–347PubMedGoogle Scholar
  113. Peachman KK, Rao M, Alving CR (2003) Immunization with DNA through the skin. Methods 31:232–242PubMedGoogle Scholar
  114. Perennes F, Marmiroli B, Matteucci M, Tormen M, Vaccari L, Di Fabrizio E (2006) Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng 16:473–479Google Scholar
  115. Phanuphak P, Khaoplod P, Benjavongkulchai M, Chutivongse S, Wilde H (1990) What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously? Bull WHO 68:83–85PubMedGoogle Scholar
  116. Plotkin S, Orenstein W, Offit P (eds) (2008) Vaccines. Saunders, PhiladelphiaGoogle Scholar
  117. Pokorna D, Polakova I, Kindlova M, Duskova M, Ludvikova V, Gabriel P, Kutinova L, Muller M, Smahel M (2009) Vaccination with human papillomavirus type 16-derived peptides using a tattoo device. Vaccine 27:3519–3529PubMedGoogle Scholar
  118. Potthoff A, Schwannecke S, Nabi G, Hoffmann D, Grunwald T, Wildner O, Brockmeyer NH, Uberla K, Tenbusch M (2009) Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine 27:2768–2774PubMedGoogle Scholar
  119. Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581–587PubMedGoogle Scholar
  120. Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–1268PubMedGoogle Scholar
  121. Prausnitz MR, Bose VG, Langer R, Weaver JC (1993) Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504–10508PubMedGoogle Scholar
  122. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK (2009) Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369–393PubMedGoogle Scholar
  123. Quaak SGL, van den Berg JH, Toebes M, Schumacher TNM, Haanen J, Beijnen JH, Nuijen B (2008) GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial. Eur J Pharm Biopharm 70:429–438PubMedGoogle Scholar
  124. Quaak SGL, den Berg JHv, Oosterhuis K, Beijnen JH, Haanen JBAG, Nuijen B (2009) DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms. J Control Release 139:153–159PubMedGoogle Scholar
  125. Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM (2009) Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 4:e7152PubMedGoogle Scholar
  126. Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM (2010) Intradermal vaccination with influenza VLPs using microneedles induces superior protection to intramuscular immunization. J Virol 84:7760–7769PubMedGoogle Scholar
  127. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF (2000) Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31:521–527PubMedGoogle Scholar
  128. Resik S, Tejeda A, Lago PM, Diaz M, Carmenates A, Sarmiento L, Alemani N, Galindo B, Burton A, Friede M, Landaverde M, Sutter RW (2010) Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis 201:1344–1352PubMedGoogle Scholar
  129. Roberts LK, Barr LJ, Fuller DH, McMahon CW, Leese PT, Jones S (2005) Clinical safety and efficacy of a powdered hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23:4867–4878PubMedGoogle Scholar
  130. Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG (2008) Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One 3:e1993PubMedGoogle Scholar
  131. Roukens AHE, Gelinck LBS, Visser LG (2011) Intradermal vaccination to protect against yellow fever and influenza. Curr Top Microbiol Immunol 351:159–179Google Scholar
  132. Roxhed N, Gasser TC, Griss P, Holzapfel GA, Stemme G (2007) Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J MEMS 16:1429–1440Google Scholar
  133. Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, Culp J, Burkholder JK, Swain WF, Dixon RM, Widera G, Vessey R, King A, Ogg G, Gallimore A, Haynes JR, Heydenburg Fuller D (2000) Induction of antigen-specific CD8 + T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764–778PubMedGoogle Scholar
  134. Samuel BU, Cherian T, Sridharan G, Mukundan P, John TJ (1991) Immune response to intradermally injected inactivated poliovirus vaccine. Lancet 338:343–344PubMedGoogle Scholar
  135. Samuel BU, Cherian T, Rajasingh J, Raghupathy P, John TJ (1992) Immune response of infants to inactivated poliovirus vaccine injected intradermally. Vaccine 10:135PubMedGoogle Scholar
  136. Sangare L, Manhart L, Zehrung D, Wang CC (2009) Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine 27:1777–1786PubMedGoogle Scholar
  137. Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51:702–747PubMedGoogle Scholar
  138. Schramm-Baxter J, Mitragotri S (2004) Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release 97:527–535PubMedGoogle Scholar
  139. Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM (2006) Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24:6110–6119PubMedGoogle Scholar
  140. Stanfield JP, Bracken PM, Waddell KM, Gall D (1972) Diphtheria–tetanus–pertussis immunization by intradermal jet injection. Brit Med J 2:197–199PubMedGoogle Scholar
  141. Sullivan SP, Murthy N, Prausnitz MR (2008) Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mat 20:933–938Google Scholar
  142. Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915–920PubMedGoogle Scholar
  143. Sutter R (2009) Status of GPEI research and product development. Manufacturer’s Meeting, Geneva 30 Oct 2009.Google Scholar
  144. Takigawa M, Tokura Y, Hashizume H, Yagi H, Seo N (2001) Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Ann N Y Acad Sci 941:139–146PubMedGoogle Scholar
  145. Tang H, Wang CC, Blankschtein D, Langer R (2002) An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res 19:1160–1169PubMedGoogle Scholar
  146. Tezel A, Mitragotri S (2003) Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys J 85:3502–3512PubMedGoogle Scholar
  147. Tezel A, Sens A, Tuchscherer J, Mitragotri S (2001) Frequency dependence of sonophoresis. Pharm Res 18:1694–1700PubMedGoogle Scholar
  148. Tezel A, Sens A, Mitragotri S (2002) Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J Pharm Sci 91:444–453PubMedGoogle Scholar
  149. Tezel A, Paliwal S, Shen Z, Mitragotri S (2005) Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23:3800–3807PubMedGoogle Scholar
  150. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454–459PubMedGoogle Scholar
  151. Van den Berg JH, Nuijen B, Beijnen JH, Vincent A, Van Tinteren H, Kluge J, Woerdeman LAE, Hennink WE, Storm G, Schumacher TN, Haanen J (2009) Optimization of intradermal vaccination by DNA tattooing in human skin. Human Gene Ther 20:181–189Google Scholar
  152. Van Kampen KR, Shi Z, Gao P, Zhang J, Foster KW, Chen DT, Marks D, Elmets CA, Tang DC (2005) Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029–1036PubMedGoogle Scholar
  153. Vandermeulen G, Daugimont L, Richiardi H, Vanderhaeghen ML, Lecouturier N, Ucakar B, Preat V (2009) Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation. Pharm Res 26:1745–1751PubMedGoogle Scholar
  154. Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC, Sattentau Q, Wagner R, Wolf H, Schumacher TNM, Heeney JL, Haanen JBAG (2008) Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 26:3346–3351PubMedGoogle Scholar
  155. Wang PM, Cornwell M, Hill J, Prausnitz MR (2006) Precise microinjection into skin using hollow microneedles. J Invest Dermatol 126:1080–1087PubMedGoogle Scholar
  156. Wang PC, Wester BA, Rajaraman S, Paik SJ, Kim SH, Allen MG (2009) Hollow polymer microneedle array fabricated by photolithography process combined with micromolding technique. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Minneapolis, pp 7026–7029Google Scholar
  157. Warrell MJ (2011) Intradermal rabies vaccination: the evolution and future of pre-and post-exposure prophylaxis. Curr Top Microbiol Immunol 351:139–157Google Scholar
  158. Weniger BG, Papania MJ (2008) Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit P (eds) Vaccines. Saunders Elsevier, Philadelphia, pp 1357–1392Google Scholar
  159. Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA (1984) Immunisation of 4–6 month old Gambian infants with Edmonston–Zagreb measles vaccine. Lancet 2:834–837PubMedGoogle Scholar
  160. WHO (2005) WHO expert consultation on rabies. WHO Tech Rep Ser 931:1–88Google Scholar
  161. WHO (2007) Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 82:425–435Google Scholar
  162. WHO (2010) WHO fact sheet: smallpox. WHO, Geneva. 14 Sept 2010
  163. Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, Cormier M (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24:1653–1664PubMedGoogle Scholar
  164. Williams J, Fox-Leyva L, Christensen C, Fisher D, Schlicting E, Snowball M, Negus S, Mayers J, Koller R, Stout R (2000) Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 18:1939–1943PubMedGoogle Scholar
  165. Zhao YL, Murthy SN, Manjili MH, Guan LJ, Sen A, Hui SW (2006) Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine 24:1282–1290PubMedGoogle Scholar
  166. Zhu QY, Zarnitsyn VG, Ye L, Wen ZY, Gao YL, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang CL, Compans RW (2009) Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 106:7968–7973PubMedGoogle Scholar
  167. Zoulek G, Roggendorf M, Deinhardt F (1984) Immune response to single dose, multisite, intradermal and to intramuscular administration of vaccine against tick-borne encephalitis virus. Lancet 2:584PubMedGoogle Scholar
  168. Zoulek G, Roggendorf M, Deinhardt F, Kunz C (1986) Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus. J Med Virol 19:55–61PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Y. C. Kim
    • 1
    • 2
  • C. Jarrahian
    • 3
  • D. Zehrung
    • 3
  • S. Mitragotri
    • 4
  • M. R. Prausnitz
    • 1
  1. 1.School of Chemical and Biomolecular Engineering, Georgia Institute of TechnologyAtlantaUSA
  2. 2.Department of Microbiology and ImmunologyEmory University School of MedicineAtlantaUSA
  3. 3.PATHSeattleUSA
  4. 4.Department of Chemical EngineeringUniversity of California Santa BarbaraSanta BarbaraUSA

Personalised recommendations